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Our laboratory has recently reported that over 80% 
of patients with common vitiligo have circulating anti-
bodies to cell-surface antige n s on normal human mela-
nocyte s. The s low growth rate of these cells limits the 
a ssays that can be performed for antibody detection. We 
now have found that the an t igens defined by vitiligo 
sera on melanocytes are also expressed on FF cells, a 
r evertant line of hamster melanoma c e lls. These anti-
g ens can be detected both by indirect immunofluores-
c ence and speci fic immunoprecipitation assays. The 
presence of "vitiligo" antigens on hamster FF cells will 
a id further study of the abnormal immune response in 
v itiligo. 
P r ogress in understandin g the pathoge nesis of vit iligo has 
been limited by difficult ies in studying t his d isease in vit ro. 
Recently, n orma l human m e la nocytes have been grown in cell 
cult ure [1] m a king it possible to develop sen sit ive and qua n t i-
t a t ive assays of t he immune response to pigmen ted cells in 
vitiligo. Us ing t h ese cells , we have dem onstrated that most 
individua ls [2,3 ], as we ll as a nima ls (4], with t his disease ha ve 
a n t ibo dies to pigmen t cells. The a n t ibodies a re directed to 
sever a l ce ll -surface a n t igens, "v it iligo a n t igens," wit h M, of 
75K , 85K , a nd 240- 250K which a re selectively expressed by 
p igment cells. These findin gs indicate t hat vit iligo is a ssociated 
with a n immune response to pigm en t cell a n t igens a nd suggest 
that i t is a n a utoimmune disease. H owever , con t inued studies 
of immune abnormalit ies in vit iligo a re limited by t he fastidi-
ousness of m elanocytes a nd t he difficul t ies in m a intaining t hem 
in c ult ure. 
W e now report t hat t he establis hed ha mster cell line, t he FF, 
expresses t he vi t iligo a ntigens. The FF line is a rever tan t cell 
lin e o f ha m ster melanocytic origin which has regained the 
cap aci t y for de ns ity-dependen t growt h [5,6]. The presen ce_ of 
t he v i t i ligo anti ge ns o n FF cells provides a n additional celllm e 
that will facilitate s tudies of immune a bnormalit ies in vi t iligo. 
MATERIALS AND METHODS 
Sera 
Studies were conducted with sera from 15 persons wi th vit iligo and 
12 no rmal individuals. All vit iligo sera were previously shown to have 
antibodi es to surface antigens on melanocytes 13]. 
Cells 
FF a nd RPM! (Roswell Park Memoria l Institute) 1846 cells were 
main tained in Falco n T30 fl asks in RPM! 164 0 medium containing 
Manuscript received March 29, 1984; accepted fo r publication June 
13, 1984. 
Supp o rted in part by NIH research grants CA13844 and AM27663 
and a con tract from Bion Corporation. 
Rep rint requests to: J ean-Claude Bystryn, M.D., Department of 
Dermatology, NYU School of Medicine, 560 First Avenue, New York, 
New York 10016. 
Abbre viations: 
C IF: contact inhibito ry factor 
F F : a reve rta nt cell line of hamster melanocytic origin 
PAGE: polyacrylamide gel electrophoresis 
PBS: phosphate-buffered saline 
SDS: sodium dodecyl sulfate 
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10% fetal ca lf se rum (G IBCO, Grand Island, New Yo rk) , 2 U/ ml 
penicillin (G IBCO), 2 11g/ml streptomycin (GIBCO) , 10 mg/ ml gent.a-
mycin (Irvine Scientific, Santa Ana, Ca li fornia), and 0.5 11gf ml fungi -
zone (Irvine Scient ific). Mediu m was changed biweekly, and cells 
subcultured every 2 wee ks. Human melanocytes were maintained in 
cul ture as previously desc ri bed r 11. 
FF is an aneuploid, contact inhibi ted hamster cell li ne. It was der ived 
from the hamster amela notic mali gnant melanoma cell line, RPM! 
1846, during experimental studies of reverse transfo rmation by nucleic 
ac ids from benign blue nevi of hamste rs [5,6]. 
Radio iodination 
Cell -surface mac romolecules were radioiod inated by the lactoperox-
idase t~chnique as previously desc ribed [2] . Cell viability fo llowing 
IOdinatiOn was over 90- 95% by trypan blue exclusion. Labeled cells 
were t horoughly washed and solu bilized in 0.5% NP-40. Particu late 
matter was removed by centri fugation at 12,000 g x 20 mi.n. 
Assays 
Radioactivity associated with labeled macromolecules was measured 
afte r precipi tation with 10% trichloroacetic acid [7]. 
. Antibodies to labeled surface ant igens we re assayed by immunopre-
Cipl tatwn Wlth protein A-sepharose [2]. Briefl y, 0. 1 ml of a 1:10 dilution 
of serum was incubated wi th 0.1 ml of radioiodinated cell lysate at 4 •c 
for 12 h, a_nd bound antigens were immunoprecipi tated by incubatin g 
Wi t h protem A-sepharose at 4•c for 2 h. All assays were performed in 
duplicate and the average value was recorded. Variation among repli -
cate samples was less t han 0.8%. T here was a linea r re lation betwee n 
the d ilut ion of viti ligo serum used in the assay and specifica lly bound 
rad1oactivity, suggestmg that the assay provides a quantitative measu re 
of antibodies to melanocyte-associated ant igens [3). Using our estab-
lished cri te ria lo r vit iligo antibodies (precipitation of 2.5% or more of 
acid-insoluble radioactivity) , all patients with vitiligo had ant ibodies 
to melanocytes. 
Polyacrylamide Gel Electrophoresis (PAGE) 
lmmunoprecipi tates generat.ed with vit iligo a nd normal sera were 
examin ed by sodium dodecyl sulfate (SDS)-8% P AGE under reducin"' 
condit ions and radioautography as previously described [8]. " 
Immunofluorescence Assays 
Cells were plated in wells of microlite r plates (Lab-Tek Div., Miles 
Laboratones, Inc., Naperville, Illinois) at a density of 5 x 103 cells/ 
we ll 111 0.5 ml of cul ture media, and incubated at 37•c for 24 h. T he 
cells were washed 3 t imes wi th 0.7 ml of Hanks' buffe red salt solution 
per well , incubated wi th 0.5 ml of test serum di luted 1:10 in phosphate-
buffered saline (P BS) for 30 min at 37•c, washed 3 t imes with 0.7 ml 
of PBS and reincubated for 30 min with tluorescein-conjugated goat 
ant ihuman lgG (Hyland Diagnostics, Deerfield, Ill inois) di luted 1:40 in 
PBS. The cells were washed again 3 t imes with PBS and examined 
immediate ly with a Nikon binocular microscope (Nikon Inc., Garden 
City, New York) equ ipped to detect immunofluorescence. 
RESULTS 
The resu lts obtained when vitiligo a nd normal human sera 
were tested for reactivity against norma l human m elanocytes 
and ha mster FF and RPMI 1846 cells by immunoprecipitation 
are summa rized in Table I. As previously sh own, vitiligo, but 
not normal sera, reacted strongly wit h radioiodinated surface 
antige ns on norma l huma n m ela nocytes . Strong reactiv ity was 
a lso observed between vi t iligo, but not norma l, sera a nd the FF 
cells. T hese diffe re nces we re highly significant (p < 0.0005). 
By con t rast, vitiligo sera reacted poorly, and to no greater 
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TABLE I. Reactivity of vitiligo antibodies with normal, revertant, and 
malignant mela.nocytic cells 
% Acid-im<olub le radioaCI.ivity immunoprecipitat.ed" 
Diagnos is Sera no. Normal human FF cells HPMI 1846 
melanocytes 
Viti ligo 1 4.1 3.8 1.2 
2 9.8 61 1.7 
3 3.8 2.9 0 
4 5.2 4.4 2.0 
5 7 . .3 6.7 1.9 
6 6.4 5.7 2.1 
7 7.6 6.8 0.9 
8 5.8 4.4 1.1 
9 4.9 3.7 0.7 
10 8.6 7.1 1.8 
11 4.7 3.2 1.1 
12 5.4 3.1 1.1 
13 .3 .9 2.8 0.7 
14 4.3 2.9 0.3 
15 4.7 3.6 0.9 
Average 5.77 ± L82(A) 4.48 ± 1.57(8) 1.17 ± 0.63(C) 
Normal 1 1.9 2.0 1.7 
2 0.7 1.7 1.4 
3 0.4 1.6 0.6 
4 1.1 1.4 1.5 
5 1.4 1.4 1.7 
6 1.7 1.8 0. 2 
7 0.5 1.6 0.4 
8 0.8 0.9 1.1 
9 0.9 1.7 0.4 
10 1.2 1.0 1.0 
Average 1.06 ± 0.49(0) 1.51 ± 0.35(E) 1.0 ± 0.57(F) 
A VS D (p < 0.0005); B VS E (p < 0.005) ; c vs F (p > 0.25); A vs c 
(p < 0.0005); B vs C (p < 0.0005) . 
• Calcula ted from: 
(cpm immunoprecipitaLed by serum) 
X 100 
acid-insoluble cpm in '" '!-labe led ce ll lysates 
100 -
11 6 -
91 -
66-
31 -
F1c 1. Radioautograph of SDS-PAGE prolile of dete rgent-soluble, 
radioiodina ted surface macromolecules of normal huma n melanocytes 
(lanes I, 2, 3 ) and FF cells (lanes 4, 5, 6) immunoprecipitated by sera 
of patients with vi t iligo ( lanes 1, 2, 4, 5 ) and normal individuals (lanes 
3, 6). 
extent than normal sera, with RPMI 1846 cells. The vitiligo 
sera used in this study had previously been shown to be non-
reactive to a number of other control cell s including hepatoma, 
colon carcinoma, fibroblasts, etc. (9]. These results indicate 
t.hat FF ce lls are useful as target cells for assay of vitiligo 
antibodies. 
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The surface antigens reacting with vitiligo antibodies on FF 
ce lls were identified by SDS-PAGE ana lysis of specific immu-
noprecipitates generated in a similar manner from detergent 
lysates of radioiodinated normal human melanocytes and FF 
cells. The results are illustrated in Fig 1. Vitiligo sera immu -
noprecipitated 3 radioiodinated antigens from both melano-
cytes and FF cells. On the basis of their migration through 
polyacrylamide the antigens defined on both cell lines were 
similar, with M, of 75K, 85K, and 240- 250K. None of these 
antigens was immunoprecipitated by normal human sera. 
Indirect immunofluorescence testing showed that vitiligo 
sera reacted to human melanocytes and FF cells, giving a 
granular pattern of fluorescence. With appropriate focusing the 
staining could be seen to involve the cell surface (Fig 2a) . 
Seventy percent or more of the FF cells reacted with viti ligo 
sera whereas only 5% or less of t he RPMI 1846 cells did so (Fig 
2b) . No positive granular staining was noted with the 12 normal 
human control sera against human melanocytes, FF cells, or 
RPM11846. 
DISCUSSION 
The results of t his study indicate that hamster FF cells 
express vitiligo antigens. These antigens are defined by sera of 
F IG 2. a., lmmunol1uoresce nce photomicrograph of unfixed FF cells 
reacted with vitiligo serum. A positive reaction is seen as bright granular 
lluorescence on t he surface of t he ce lls . Original magnification x 400. 
b, indirect immuno11uorescence of unfixed RPM! 1846 cells reac ted 
with vitiligo serum. Bright 11uorescence is absent. 
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patients wit h vit iligo and can be detected by both indirect 
immunofluorescence and specific immunoprecipitation assays. 
B oth the amou nt of vitiligo antigen expressed by t hese cells (as 
determined from the amount of radioactivity immunoprecipi -
tated by vit iligo se ra) and their nature (as defined by migration 
o n SDS-PAGE) a re simila r to the amoun t and type of vitiligo 
antigen expressed by normal human melanocytes. Migration 
patterns on SDS-PAGE indicate that t he antigens precipitated 
by v itiligo se ra have M , of 75K, 85K, and 240-250K. The 
cellula r location and migration pattern of these antigens is 
identical to those seen on normal human melanocytes. 
Indirect immunofluorescence testing confirmed that the im-
rnunoprecipi tation assay was measuring ant ibodies directed to 
antigens on t he FF cell line. Vitiligo sera reacted strongly to 
FF ce lls but not to the RPMI 1846 cells. A correlation was seen 
between the intensity of granular staining and the binding 
activity of t he sera as found by specific immunoprecipitation. 
These findin gs indicate that FF cells provide a suitable 
cellular substrate for studies of immune abnormalities in viti -
ligo. The observation that the vitiligo ant igens are present on 
t he revertant FF cell line but not on t he malignant RPMI 1846 
cell s i s interesting for several reasons. It demonstrates that a 
phenotypically revertant melanocytic ce ll line has reexpressed 
several differentiation antigens absent in the malignant paren-
tal line. It also shows that these ant igens are common to 
melanocytes of both hamster and human origins, since hamster 
cell s react with antibodies generated in human vit iligo patients . 
The hamster FF line bearing these different iation antigens has 
previous ly been shown to produce a diffusible contact inhibitory 
factor (CIF) which restores the capacity for density-dependent 
growth to malignant melanocytes of hamster [10], murin~ [ll_] , 
and human [ll] origins. Therefore it is fascinating to fmd m 
our most recent studies t hat CIF also induces the expression of 
all 3 vitiligo antigens on malignant melanoma cells of both 
human and mouse.* Furt her investigation of the appearance of 
* Lipkin G, Naught on GK, Bystryn J -C, Rose nberg M: Vit iligo-
related p igment cell differentiation antigens a re expressed on malignant 
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t hese antigens will help in the evaluation of the role of these 
cell -surface proteins in the pathogenesis of vitiligo. 
The excellent techn ica l assistance of Georgette Durand is gratefully 
acknowledged. Drs. Dorothy Kim Lee and Mart in Rosenberg provided 
very helpful discussions. 
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